Imperagen, a biotechnology firm originating from the Manchester Institute of Biotechnology, has successfully closed a £5 million ($6.7 million) seed funding round. The investment, led by PXN Ventures with additional support from IQ Capital and Northern Gritstone, brings the company’s total funding to £8.5 million. Founded in 2021 by scientists Dr. Andrew Currin, Dr. Tim […]